image
Healthcare - Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
INCOME STATEMENT
145 M REVENUE
-0.55%
-119 M OPERATING INCOME
7.79%
-76.4 M NET INCOME
46.60%
EFFICIENCY
Earnings Waterfall Karyopharm Therapeutics Inc.
image
Revenue 145 M
Cost Of Revenue 6.01 M
Gross Profit 139 M
Operating Expenses 259 M
Operating Income -119 M
Other Expenses -43 M
Net Income -76.4 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 145.2 146.0 157.1 209.8 108.1 40.9 30.3 1.6 0.2 0.2 0.2 0.4 0.6 0.2
GROSS PROFIT
Cost Of Revenue 6.0 4.9 5.2 3.4 2.7 2.4 161.4 107.3 86.9 97.7 60.1 28.5 14.1 0
Gross Profit 139.2 141.1 151.9 206.4 105.4 38.5 (131.0) (105.7) (86.8) (97.5) (59.9) (28.1) (13.5) 0.2
OPERATING INCOME
Operating Expenses 258.7 270.6 294.1 304.7 277.2 227.8 210.2 132.1 110.9 119.3 76.1 34.3 16.5 10.5
Selling, General and Administrative Expenses 115.4 131.9 145.4 143.8 126.4 105.4 48.8 24.9 23.9 21.6 15.9 5.9 2.4 1.8
Research and Development Expenses 143.2 138.8 148.7 160.8 150.8 122.3 161.4 107.3 86.9 97.7 60.1 28.5 14.1 8.6
Operating Income (119.4) (129.5) (142.2) (98.3) (171.8) (189.3) (179.9) (130.5) (110.7) (119.1) (75.8) (34.0) (15.9) (10.3)
PRE-TAX INCOME
Interest Income Expense 37.4 23.8 25.0 26.0 27.1 15.6 2.5 0 0 0 1 K 0 0 0
Total Other Income 43.1 (13.2) (22.7) (25.5) (24.1) (10.3) 1.5 1.6 1.3 0.9 69 K 3 K 2 K 0
Pre-Tax Income (76.4) (142.8) (164.9) (123.8) (196.0) (199.6) (178.4) (128.9) (109.4) (118.2) (75.8) (33.9) (15.9) (10.3)
NET INCOME
Tax Provision 57 K 0.3 0.4 0.3 0.3 40 K 26 K 63 K 0.1 (0.9) 69 K 3 K 2 K 0
Net Income (76.4) (143.1) (165.3) (124.1) (196.3) (199.6) (178.4) (129.0) (109.6) (118.2) (75.8) (33.9) (15.9) (10.3)
EPS 0.63 1.25 2.02 1.65 2.72 3.22 3.14 2.81 2.92 3.32 2.43 5.59 6.64 10.3